BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Head and neck cancer AND MLH1, COCA2, 4292, ENSG00000076242, hMLH1, FCC2, HNPCC2, P40692, MGC5172, HNPCC AND Treatment
36 results:

  • 1. Genetic variability in cisplatin metabolic pathways and outcome of locally advanced head and neck squamous cell carcinoma patients.
    Ferreira AMC; Altemani JMC; Macedo LT; Lourenço GJ; Lima CSP
    Sci Rep; 2023 Oct; 13(1):16762. PubMed ID: 37798436
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Predictive biomarkers of immunotherapy response with pharmacological applications in solid tumors.
    Kovács SA; Fekete JT; Győrffy B
    Acta Pharmacol Sin; 2023 Sep; 44(9):1879-1889. PubMed ID: 37055532
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Fusobacterium nucleatum impairs DNA mismatch repair and stability in patients with squamous cell carcinoma of the head and neck.
    Hsueh CY; Lau HC; Huang Q; Gong H; Sun J; Cao P; Hu C; Zhang M; Tao L; Zhou L
    Cancer; 2022 Sep; 128(17):3170-3184. PubMed ID: 35789992
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Correlation of mismatch repair deficiency with clinicopathological features and programmed death-ligand 1 expression in thyroid carcinoma.
    Qiao PP; Tian KS; Han LT; Ma B; Shen CK; Zhao RY; Zhang Y; Wei WJ; Chen XP
    Endocrine; 2022 Jun; 76(3):660-670. PubMed ID: 35366156
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The DNA damage response network in the treatment of head and neck squamous cell carcinoma.
    Psyrri A; Gkotzamanidou M; Papaxoinis G; Krikoni L; Economopoulou P; Kotsantis I; Anastasiou M; Souliotis VL
    ESMO Open; 2021 Apr; 6(2):100075. PubMed ID: 33714009
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Micronuclei Formation upon Radioiodine Therapy for Well-Differentiated Thyroid cancer: The Influence of DNA Repair Genes Variants.
    S Santos L; M Gil O; N Silva S; C Gomes B; C Ferreira T; Limbert E; Rueff J
    Genes (Basel); 2020 Sep; 11(9):. PubMed ID: 32957448
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Mismatch repair protein loss in cutaneous head and neck squamous cell carcinoma.
    Vasan K; Anand S; Satgunaseelan L; Asher R; Low H; Palme CE; Lee JH; Clark JR; Gupta R
    J Surg Oncol; 2020 Dec; 122(8):1755-1760. PubMed ID: 32926758
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Evaluation of PARP and PDL-1 as potential therapeutic targets for women with high-grade neuroendocrine carcinomas of the cervix.
    Carroll MR; Ramalingam P; Salvo G; Fujimoto J; Solis Soto LM; Phoolcharoen N; Hillman RT; Cardnell R; Byers L; Frumovitz M
    Int J Gynecol Cancer; 2020 Sep; 30(9):1303-1307. PubMed ID: 32727929
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Metastatic rectal cancer to papillary thyroid carcinoma: a case report and review of literature.
    Luo M; Huang Y; Li Y; Zhang Y
    BMC Gastroenterol; 2020 May; 20(1):136. PubMed ID: 32375670
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Characterization of novel genetic alterations in salivary gland secretory carcinoma.
    Na K; Hernandez-Prera JC; Lim JY; Woo HY; Yoon SO
    Mod Pathol; 2020 Apr; 33(4):541-550. PubMed ID: 31822803
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. No Evidence of Microsatellite Instability and Loss of Mismatch-Repair-Protein Expression in Squamous Cell Carcinoma of the Penis.
    Stoehr R; Wendler O; Giedl J; Gaisa NT; Richter G; Campean V; Burger M; Wullich B; Bertz S; Hartmann A
    Pathobiology; 2019; 86(2-3):145-151. PubMed ID: 30650417
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Time to Separate Persistent From Recurrent Differentiated Thyroid cancer: Different Conditions With Different Outcomes.
    Sapuppo G; Tavarelli M; Belfiore A; Vigneri R; Pellegriti G
    J Clin Endocrinol Metab; 2019 Feb; 104(2):258-265. PubMed ID: 30165559
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Cutaneous Metastasis of Adenocarcinoma of the Ampulla of Vater.
    Fernandez-Flores A; Cassarino DS
    Am J Dermatopathol; 2018 Oct; 40(10):758-761. PubMed ID: 29672360
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Analysis of clinically relevant somatic mutations in high-risk head and neck cutaneous squamous cell carcinoma.
    Zilberg C; Lee MW; Yu B; Ashford B; Kraitsek S; Ranson M; Shannon K; Cowley M; Iyer NG; Palme CE; Ch'ng S; Low TH; O'Toole S; Clark JR; Gupta R
    Mod Pathol; 2018 Feb; 31(2):275-287. PubMed ID: 28984303
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Using Ion Torrent sequencing to study genetic mutation profiles of fatal thyroid cancers.
    Lu JY; Cheng WC; Chen KY; Lin CC; Chang CC; Kuo KT; Chen PL
    J Formos Med Assoc; 2018 Jun; 117(6):488-496. PubMed ID: 28757314
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. GSTP1 c.313A>G, XPD c.934G>A, XPF c.2505T>C and CASP9 c.-1339A>G Polymorphisms and Severity of Vomiting in head and neck cancer Patients treated with Cisplatin Chemoradiation.
    Carron J; Lopes-Aguiar L; Costa EFD; Nogueira GAS; Lima TRP; Pincinato EC; Visacri MB; Quintanilha JCF; Moriel P; Lourenço GJ; Lima CSP
    Basic Clin Pharmacol Toxicol; 2017 Dec; 121(6):520-525. PubMed ID: 28686330
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. In vitro study of human mutL homolog 1 hypermethylation in inducing drug resistance of esophageal carcinoma.
    Cao Y; Chen Y; Huang Y; Liu Z; Li G
    Ir J Med Sci; 2017 May; 186(2):257-263. PubMed ID: 26782688
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Phase II clinical and exploratory biomarker study of dacomitinib in recurrent and/or metastatic esophageal squamous cell carcinoma.
    Kim HS; Kim SM; Kim H; Pyo KH; Sun JM; Ahn MJ; Park K; Keam B; Kwon NJ; Yun HJ; Kim HG; Chung IJ; Lee JS; Lee KH; Kim DJ; Lee CG; Hur J; Chung H; Park JC; Shin SK; Lee SK; Kim HR; Moon YW; Lee YC; Kim JH; Paik S; Cho BC
    Oncotarget; 2015 Dec; 6(42):44971-84. PubMed ID: 26462025
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Identification of methylation markers for the prediction of nodal metastasis in oral and oropharyngeal squamous cell carcinoma.
    Melchers LJ; Clausen MJ; Mastik MF; Slagter-Menkema L; van der Wal JE; Wisman GB; Roodenburg JL; Schuuring E
    Epigenetics; 2015; 10(9):850-60. PubMed ID: 26213212
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. The hmlh1 -93G>A promoter polymorphism is associates with outcomes in oral squamous cell carcinoma patients.
    Lin LH; Lin MW; Mar K; Lin CS; Ji DD; Lee WP; Lee HS; Cheng MF; Hsia KT
    Ann Surg Oncol; 2014 Dec; 21(13):4270-7. PubMed ID: 25047469
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.